2,8-diazaspiro[5.5]undecan-3-one dihydrochloride, 95.0%, 250mg

2,6-Dimethylheptan-4-amine hydrochloride, 95%, 250mg

Diethyl phenylphosphonate, 96.0%, 25ml

2-(2,4,6-trichlorophenoxy)acetic acid, 98.0%, 10g

2-(Bromoacetyl)pyridine hydrobromide, 95.0%, 10g

4-BROMO-N,N-DIMETHYL-1H-PYRAZOLE-1-SULFONAMIDE, 95%, 1g

1,2,3,4,5,6-Hexa-O-[11-[4-(4-hexylphenylazo)phenoxy]undecanoyl]-D-mannitol>97.0%(HPLC)1g

Ethyl 4-methyl-2-(methylthio)pyrimidine-5-carboxylate, 95.0%, 5g

(R)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate, 95.0%, 100mg

Dimethyl 2-methylisophthalate, 95.0%, 250mg

Glycerol Dimethacrylate (mixture of 1,2- and 1,3-form) (stabilized with MEHQ)>90.0%(GC)25g

Plan PLMi 5x/0.12 infinity corrected IOS objective. Working distance 26.1 mm

3-ETHYNYL-PYRIDAZINE, 95.0%, 250mg